A Medscape survey found that a strong majority of physicians believe high-risk patients should have easier access to new weight loss drugs.
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...
Leading health experts challenge traditional BMI measurements and introduce a comprehensive new approach to diagnosing obesity, potentially affecting millions.
Cancer researchers found that patients on GLP-1s had significant risk reductions for 10 of 13 obesity-associated cancers.
An international team of doctors proposed a new way to define obesity that's not based solely on BMI. Here's what they ...
Over 75 medical organisations worldwide have endorsed the new definitions, reflecting a growing consensus for reform.
An international commission made the case for focusing on body fat quantity and the illnesses people experience.
A group of global experts is proposing a new way to define and diagnose obesity, reducing the emphasis on the controversial body mass index and hoping to better identify people who need ...
New Rule Seeks to Expand Medicare and Medicaid Coverage of Weight Loss Drugs. The Biden Administration has proposed a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback